TTFields: where does all the skepticism come from?

Por Wick, Wolfgang
Publicado no Neuro Oncol (2016)

Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?

Por Weller, Michael, Wick, Wolfgang
Publicado em 2011

Trabedersen to target transforming growth factor-β: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132–142)

Por Wick, Wolfgang, Weller, Michael
Publicado em 2011

CMV infection and glioma, a highly controversial concept struggling in the clinical arena

Por Wick, Wolfgang, Platten, Michael
Publicado em 2014

Tregs in gliomas – the jury is still out

Por Platten, Michael, Wick, Wolfgang
Publicado no Neuro Oncol (2015)

Modulation of MDR/MRP by wild-type and mutant p53

Por Bähr, Oliver, Wick, Wolfgang, Weller, Michael
Publicado em 2001

New (alternative) temozolomide regimens for the treatment of glioma

Por Wick, Wolfgang, Platten, Michael, Weller, Michael
Publicado em 2009

The aryl hydrocarbon receptor in tumor immunity

Por Platten, Michael, Litzenburger, Ulrike, Wick, Wolfgang
Publicado em 2012

Challenging cytomegalovirus data in glioblastoma

Por Wick, Wolfgang, Wick, Antje, Platten, Michael
Publicado em 2014

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferon-γ (IFN-γ)

Por Platten, Michael, Wick, Wolfgang, Wischhusen, Jörg, Weller, Michael
Publicado em 2001

Highlights from the Literature

Por Soffietti, Riccardo, Pope, Whitney, Schiff, David, Wick, Wolfgang
Publicado em 2014

Mutant IDH1: An immunotherapeutic target in tumors

Por Schumacher, Theresa, Bunse, Lukas, Wick, Wolfgang, Platten, Michael
Publicado no Oncoimmunology (2015)

Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

Por Preusser, Matthias, Berghoff, Anna S., Wick, Wolfgang, Weller, Michael
Publicado no Clin Neuropathol (2015)

A malignant cellular network in gliomas: potential clinical implications

Por Osswald, Matthias, Solecki, Gergely, Wick, Wolfgang, Winkler, Frank
Publicado no Neuro Oncol (2016)

Standards of care for treatment of recurrent glioblastoma—are we there yet?

Por Weller, Michael, Cloughesy, Timothy, Perry, James R., Wick, Wolfgang
Publicado em 2013

The mTOR signaling pathway as a treatment target for intracranial neoplasms

Por Pachow, Doreen, Wick, Wolfgang, Gutmann, David H., Mawrin, Christian
Publicado no Neuro Oncol (2015)

Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy

Por Reardon, David A., Gilbert, Mark R., Wick, Wolfgang, Liau, Linda
Publicado no Neuro Oncol (2015)

Highlights from the Literature

Por Lawler, Sean, Schiff, David, Wick, Wolfgang, Chamberlain, Marc, Wright, Karen
Publicado no Neuro Oncol (2016)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors

Por Platten, Michael, von Knebel Doeberitz, Nikolaus, Oezen, Iris, Wick, Wolfgang, Ochs, Katharina
Publicado no Front Immunol (2015)

Highlights from the Literature

Por Pope, Whitney, Huse, Jason, Abounader, Roger, Purow, Benjamin, Wick, Wolfgang, Aldape, Kenneth
Publicado no Neuro Oncol (2017)